AlgoMD is a clinical AI research company based in Pune, India. It builds algorithms for patients that existing clinical tools were not built on, starting with India, and publishes research documentation for each one. Its pipeline includes NETRA; CardioPredict-India (CPI), for cardiovascular risk; INDIRA, for locoregional recurrence risk in breast cancer; and NeuroFusion-AD (NFAD), for amyloid and cognitive-decline risk in mild cognitive impairment. CPI and INDIRA are designed for review by India's CDSCO, and NFAD for the EU MDR. All AlgoMD algorithms are research-stage and are not available for clinical use. More at algo-md.com.
Please don’t recolour, stretch or add effects to the mark. Leave clear space around it equal to half its height.
High-resolution download and photo credit to be added.